This clinical trial studies eliminating surgery and/or radiation therapy in treating breast cancer patients. In HER2 positive and triple negative breast cancer…

Estrogen Receptor NegativeHER2 Positive Breast CarcinomaHER2/Neu Negative+9 more

~Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT02945579

Phase 2

I-CURE-1: A Phase II, Single Arm Study of Pembroluzimab Combined With Carboplatin in Patients With Circulating Tumor Cells (CTCs) Positive Her-2 Negative Metastatic Breast Cancer (MBC)

The purpose of the study is to evaluate the impact on progression-free survival (PFS) with the combination carboplatin - pembrolizumab in patients with CTC (ci…

Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+4 more

~Estimated

~$10 – $6,250

Northwestern UniversityNCT03213041